0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2016;315(5):510-511. doi:10.1001/jama.2016.0048.

Viewpoint | 
Meredith Y. Smith, PhD, MPA; Paul J. Seligman, MD, MPH
JAMA. 2015;314(17):1793-1794. doi:10.1001/jama.2015.11871.

Editorial | 
Joshua M. Sharfstein, MD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2015;314(3):233-234. doi:10.1001/jama.2015.7151.

Editorial | 
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD; Robert M. Golub, MD
JAMA. 2015;314(3):235-236. doi:10.1001/jama.2015.8232.

News From the Centers for Disease Control and Prevention | 
Anita Slomski, MA
JAMA. 2015;314(2):116. doi:10.1001/jama.2015.7236.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(1):17. doi:10.1001/jama.2015.7109.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4114.

Editorial | 
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567.

Original Investigation |  FREE
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809.
Includes: Supplemental Content

Original Investigation |  FREE
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Dermatology
Original Investigation  | 
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
Frank I. Scott, MD, MSCE; Ronac Mamtani, MD, MSCE; Colleen M. Brensinger, MS; et al.
JAMA Internal Medicine
Editorial  | 
Vitamin D Supplementation and Increased Risk of Falling A Cautionary Tale of Vitamin Supplements Retold
Steven R. Cummings, MD; Douglas P. Kiel, MD, MPH; Dennis M. Black, PhD